Do a search on www.pubmed.com for "mitoQ"
looks very promising!!!
Sean
www.abolitionist-society.com
Posted 03 June 2004 - 01:42 AM
Posted 03 June 2004 - 02:02 AM
Posted 03 June 2004 - 02:32 AM
Posted 03 June 2004 - 03:38 PM
Posted 04 June 2004 - 03:48 PM
Posted 04 June 2004 - 03:58 PM
Posted 05 June 2004 - 06:53 PM
Posted 05 June 2004 - 09:05 PM
Posted 06 June 2004 - 12:57 AM
Swell; but what are the dose sizes for humans? Per dose/per day?
I will order some if the prices are reasonable per dose. Does anybody have any experience ordering products from Team L.I.F.E. Research?
Posted 06 June 2004 - 01:09 AM
Posted 06 June 2004 - 07:14 AM
Posted 13 June 2004 - 12:01 AM
Posted 13 June 2004 - 04:32 AM
Edited by prometheus1, 13 June 2004 - 05:10 AM.
Posted 13 June 2004 - 04:34 AM
Posted 13 June 2004 - 05:12 AM
Posted 25 July 2004 - 09:28 PM
Sure, very interested. Where do you get it from?
Posted 25 July 2004 - 10:32 PM
Sure, very interested. Where do you get it from?
Just so everyone knows, MitoQ is actually mitochondrial-targeted idebenone, and not CoQ10.
Idebenone has been revealed to substantially increase production of superoxide by up to 20-fold
recently, raising questions as to whether the net effect may be negative. Of course,
since most superoxide is produced in the mitochondria, MitoQ would theoretically be especially effective at
raising superoxide levels.
Mito-VitE and MitoPBN are two others.
The most promising research chemical for reducing oxidative stress on the horizon is probably STAZN. There will probably be a mitochondria-targeted form of it eventually.
See the following info someone recently posted to usenet:
http://tinyurl.com/44hov
Posted 27 July 2004 - 06:01 PM
Sure, very interested. Where do you get it from?
Just so everyone knows, MitoQ is actually mitochondrial-targeted idebenone, and not CoQ10.
Idebenone has been revealed to substantially increase production of superoxide by up to 20-fold
recently, raising questions as to whether the net effect may be negative.
Of course, since most superoxide is produced in the mitochondria, MitoQ would theoretically be especially effective at
raising superoxide levels.
The most promising research chemical for reducing oxidative stress on the horizon is probably STAZN. There will probably be a mitochondria-targeted form of it eventually.
See the following info someone recently posted to usenet:
http://tinyurl.com/44hov
Posted 22 October 2006 - 02:54 PM
J Biomed Biotechnol. 2006;2006(3):31372.
Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics.
* Reddy PH.
The overall aim of this article is to review current therapeutic strategies for treating AD, with a focus on mitochondrially targeted antioxidant treatments. Recent advances in molecular, cellular, and animal model studies of AD have revealed that amyloid precursor protein derivatives, including amyloid beta (A beta) monomers and oligomers, are likely key factors in tau hyperphosphorylation, mitochondrial oxidative damage, inflammatory changes, and synaptic failure in the brain tissue of AD patients. Several therapeutic strategies have been developed to treat AD, including anti-inflammatory, antioxidant, and antiamyloid approaches. Among these, mitochondrial antioxidant therapy has been found to be the most efficacious in reducing pathological changes and in not producing adverse effects; thus, mitochondrial antioxidant therapy is promising as a treatment for AD patients. However, a major limitation in applying mitochondrial antioxidants to AD treatment has been the inability of researchers to enhance antioxidant levels in mitochondria. Recently, however, there has been a breakthrough. Researchers have recently been able to promote the entry of certain antioxidants-including MitoQ, MitoVitE, MitoPBN, MitoPeroxidase, and amino acid and peptide-based SS tetrapeptides-into mitochondria, several hundred-fold more than do natural antioxidants. Once in the mitochondria, they rapidly neutralize free radicals and decrease mitochondrial toxicity. Thus, mitochondrially targeted antioxidants are promising candidates for treating AD patients.
PMID: 17047303 [PubMed - in process]
Posted 24 October 2006 - 09:08 AM
Posted 07 August 2013 - 08:34 PM
Posted 07 August 2013 - 09:45 PM
Potential use of MitQ for IBS:
http://blogs.biomedc...-bowel-disease/
Posted 08 August 2013 - 05:53 AM
Posted 08 August 2013 - 12:27 PM
Posted 28 December 2013 - 02:05 PM
Edited by Boris_Badenoff, 28 December 2013 - 02:06 PM.
Posted 28 December 2013 - 02:23 PM
Posted 28 December 2013 - 02:35 PM
Wow, it finally made it to market! I would have been very excited about this a few years ago, but now we have C60-oo that I think works in a similar manner, only better. The MitoQ paper didn't actually reverse MS. It acted as an anti-inflammatory antioxidant, which subverted the method that they used to experimentally induce "an MS-like disease". I suspect C60 would have acted similarly. It would be interesting to combine MitoQ with C60-oo to see if they have any synergy.
Posted 28 December 2013 - 02:41 PM
Posted 29 December 2013 - 02:43 PM
MitoQ was once the hope of people - me included - with mitochondrial diseases. Too bad it has ended-up as a skin care product. Nevertheless, I have just ordered a bottle. It will be interesting too see its effects on my faulty mitos. I will report any significant effect.
Posted 29 December 2013 - 04:53 PM
Edited by hav, 29 December 2013 - 04:58 PM.
0 members, 25 guests, 0 anonymous users